Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Browne, Stephen
Larkin, Conall
and
O'Callaghan, Eadbhard
1999.
Outcome studies in schizophrenia.
Irish Journal of Psychological Medicine,
Vol. 16,
Issue. 4,
p.
140.
Kaiser, W.
2000.
Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life.
British Journal of Psychiatry,
Vol. 176,
Issue. 1,
p.
92.
Weiser, Mark
Shneider-Beeri, Michal
Nakash, Nitza
Brill, Noa
Bawnik, Odelia
Reiss, Shoshana
Hocherman, Shraga
and
Davidson, Michael
2000.
Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?.
Schizophrenia Research,
Vol. 46,
Issue. 2-3,
p.
81.
O'Carroll, Ronan
2000.
Cognitive impairment in schizophrenia.
Advances in Psychiatric Treatment,
Vol. 6,
Issue. 3,
p.
161.
Aleman, André
and
de Haan, Edward H. F.
2000.
Antipsychotics and Working Memory in Schizophrenia.
Science,
Vol. 289,
Issue. 5476,
p.
56.
Lublin, H.
2001.
Cognitive dysfunction in schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 104,
Issue. s408,
p.
5.
Sumiyoshi, Tomiki
Matsui, Mie
Yamashita, Ikiko
Nohara, Shigeru
Kurachi, Masayoshi
Uehara, Takashi
Sumiyoshi, Sawako
Sumiyoshi, Chika
and
Meltzer, Herbert Y
2001.
The effect of tandospirone, a serotonin1A agonist, on memory function in schizophrenia.
Biological Psychiatry,
Vol. 49,
Issue. 10,
p.
861.
Jogems-Kosterman, B.J.M
Zitman, F.G
Van Hoof, J.J.M
and
Hulstijn, W
2001.
Psychomotor slowing and planning deficits in schizophrenia.
Schizophrenia Research,
Vol. 48,
Issue. 2-3,
p.
317.
McCann, Eddie
2001.
RECENT DEVELOPMENTS IN PSYCHOSOCIAL INTERVENTIONS FOR PEOPLE WITH PSYCHOSIS.
Issues in Mental Health Nursing,
Vol. 22,
Issue. 1,
p.
99.
Harris, N. R.
Lovell, K.
and
Day, J. C.
2002.
Consent and long‐term neuroleptic treatment.
Journal of Psychiatric and Mental Health Nursing,
Vol. 9,
Issue. 4,
p.
475.
Henderson, David C.
and
Ettinger, Elissa R.
2002.
Glucose Metabolism in the Brain.
Vol. 51,
Issue. ,
p.
481.
Quraishi, Seema
and
Frangou, Sophia
2002.
Neuropsychology of bipolar disorder: a review.
Journal of Affective Disorders,
Vol. 72,
Issue. 3,
p.
209.
Curran, Stephen
Harris, Linda
Macdonald, Andrew
Pollock, Colin
Roney, Gerry
and
Silkstone, David
2002.
Antipsychotics in clinical practice: guidelines for safe and effective use.
Human Psychopharmacology: Clinical and Experimental,
Vol. 17,
Issue. 2,
p.
75.
Sharma, T.
Galea, A.
Zachariah, E.
Das, M.
Taylor, D.
Ruprah, M.
and
Kumari, V.
2002.
Effects of 10 mg and 15 mg oral procyclidine on critical flicker fusion threshold and cardiac functioning in healthy human subjects.
Journal of Psychopharmacology,
Vol. 16,
Issue. 2,
p.
183.
Weiss, Elisabeth M
Golaszewski, Stephan
Mottaghy, Felix M
Hofer, Alex
Hausmann, Armand
Kemmler, Georg
Kremser, Christian
Brinkhoff, Claudia
Felber, Stephan R
and
Wolfgang Fleischhacker, W
2003.
Brain activation patterns during a selective attention test—a functional MRI study in healthy volunteers and patients with schizophrenia.
Psychiatry Research: Neuroimaging,
Vol. 123,
Issue. 1,
p.
1.
Meltzer, Herbert
2003.
Dopamine in the Pathophysiology and Treatment of Schizophrenia.
p.
177.
Le Pen, Gwenaëlle
Grottick, Andrew J
Higgins, Guy A
and
Moreau, Jean-Luc
2003.
Phencyclidine Exacerbates Attentional Deficits in a Neurodevelopmental Rat Model of Schizophrenia.
Neuropsychopharmacology,
Vol. 28,
Issue. 10,
p.
1799.
Gemperle, A.Y
Enz, A
Pozza, M.F
Lthi, A
and
Olpe, H.R
2003.
Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study.
Neuroscience,
Vol. 117,
Issue. 3,
p.
681.
Hughes, Catherine
Kumari, Veena
Soni, William
Das, Mrigendra
Binneman, Brendon
Drozd, Sonia
O'Neil, Shaun
Mathew, Vallakalil
and
Sharma, Tonmoy
2003.
Longitudinal study of symptoms and cognitive function in chronic schizophrenia.
Schizophrenia Research,
Vol. 59,
Issue. 2-3,
p.
137.
Sumiyoshi, Tomiki
Jayathilake, Karu
and
Meltzer, Herbert Y
2003.
The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
Schizophrenia Research,
Vol. 59,
Issue. 1,
p.
7.
eLetters
No eLetters have been published for this article.